Urinary tract infections (UTIs) represent the second most common infectious disease in the United States and a significant cause of morbidity, with major economic and social impact. These infections commonly are caused by the Gram-negative bacterium Escherichia coli. Once uropathogenic E. coli (UPEC) is introduced, survival and persistence of these bacteria in the urinary tract require a specific set of virulence factors. Recent work in the murine cystitis model has revealed a pathogenic cascade of events in E. coli UTI, including bacterial attachment and internalization, followed by the formation of intracellular biofilm-like pods of bacteria within superficial facet cells of the uroepithelium. Host responses include uroepithelial production of inflammatory cytokines and an influx of neutrophils into the bladder. UPEC strains attenuate epithelial cytokine production sharply in vitro, suggesting a mechanism by which UPEC may attempt to subvert this immune response to gain a foothold within the bladder. In addition, UPEC multiply to high levels within the mouse bladder despite the presence of a significant neutrophil infiltrate. We hypothesize that UPEC employs strategies to attenuate host cytokine signaling, resist phagocytosis, survive within phagocytes, and/or affect the generation of reactive oxygen species within neutrophils. We further hypothesize that arriving neutrophils respond to specific chemical signals to target only pod-infected uroepithelial cells. This proposal blends in vitro neutrophil and tissue culture assays, bacterial genetics, the murine cystitis model, quantitative gene expression profiling, and proteomics to identify the molecular determinants of the interactions between UPEC and components of host immunity, particularly neutrophils. The results will advance our understanding of host-pathogen interactions within the bladder, offer targets for new therapeutic and preventive strategies for UTI, and provide a foundation for new paradigms in host-pathogen crosstalk that can be generalized to other Gram-negative bacterial infections.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08DK067894-03
Application #
7096516
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Moen, Laura K
Project Start
2004-08-01
Project End
2009-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
3
Fiscal Year
2006
Total Cost
$126,578
Indirect Cost
Name
Washington University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Loughman, Jennifer A; Hunstad, David A (2011) Attenuation of human neutrophil migration and function by uropathogenic bacteria. Microbes Infect 13:555-65
Horvath Jr, Dennis J; Li, Birong; Casper, Travis et al. (2011) Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coli. Microbes Infect 13:426-37
Li, Yali; Hindi, Khadijah; Watts, Kristin M et al. (2010) Shell crosslinked nanoparticles carrying silver antimicrobials as therapeutics. Chem Commun (Camb) 46:121-3
Loughman, Jennifer A; Fritz, Stephanie A; Storch, Gregory A et al. (2009) Virulence gene expression in human community-acquired Staphylococcus aureus infection. J Infect Dis 199:294-301
Nicholson, Tracy F; Watts, Kristin M; Hunstad, David A (2009) OmpA of uropathogenic Escherichia coli promotes postinvasion pathogenesis of cystitis. Infect Immun 77:5245-51
Orscheln, Rachel C; Hunstad, David A; Fritz, Stephanie A et al. (2009) contribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections. Clin Infect Dis 49:536-42
Watts, Kristin M; Hunstad, David A (2008) Components of SurA required for outer membrane biogenesis in uropathogenic Escherichia coli. PLoS One 3:e3359
Justice, Sheryl S; Lauer, Scott R; Hultgren, Scott J et al. (2006) Maturation of intracellular Escherichia coli communities requires SurA. Infect Immun 74:4793-800
Justice, Sheryl S; Hunstad, David A; Seed, Patrick C et al. (2006) Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc Natl Acad Sci U S A 103:19884-9
Hunstad, David A; Justice, Sheryl S; Hung, Chia S et al. (2005) Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect Immun 73:3999-4006

Showing the most recent 10 out of 11 publications